r&d

본문 바로가기

팝업레이어 알림

a39927f207a5b5b758989f733966718e_1569918323_4817.jpg
 

a39927f207a5b5b758989f733966718e_1569918380_161.jpg
 


회원로그인

R&D

“Delivering the spirit of love for every human-being to biotechnology”
“From Chemical Medicines to Biopharmaceuticals”

R&D

  • Laboratory in Jeju

  • Laboratory in Gyeonggi

From First generic to First-in-class

  • First generic : Hyaluronidase (liquid), Polydeoxynucleotide
  • New drug : Combination drug, Enzyme drug
  • Biopharmaceuticals : Cytokines, recombinant enzymes
  • Medical devices : patent protected medical devices

R&D from 2006

  • Biophamaceuticals
  • Combination drugs
  • Medical devices
  • Generics
  • - Selected as a leading R&D company of Jeju province

    - Developed a pharmaceutical ingredient, Polydeoxyribonucleotide from amberjack milt

  • - Began developing rHU IL-2 (Interleukin-2) for lymphocytopenia treatment

  • - Began developing a combination drug, preventing an after-cataract

    - Development of a natural product drug for anti-diabetic

  • - Began developing rHu IL-2 (Interleukin-2) for metastatic renal cell carcinoma treatment

    - Development of a liquid hyaluronidase formulation with high purity